Informing prostate cancer screening policy makers in the
European Union: lessons from cancer screening governance and
policymaking

J 2025

Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking

COLLEN, Sarah; Arunah CHANDRAN; Paolo GUGLIELMETTI; Ondřej MÁJEK; Monique J ROOBOL et al.

Základní údaje

Originální název

Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking

Autoři

COLLEN, Sarah; Arunah CHANDRAN; Paolo GUGLIELMETTI; Ondřej MÁJEK ; Monique J ROOBOL; Hendrik VAN POPPEL a Sergio TORRES-RUEDA

Vydání

European journal of public health, OXFORD, OXFORD UNIV PRESS, 2025, 1101-1262

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 3.900 v roce 2024

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/25:00141542

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

prostate cancer screening; European Union; health policy; screening governance; policymaking

Štítky

14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 18. 2. 2026 13:20, Mgr. Tereza Miškechová

Anotace

V originále

Prostate cancer (PCa) poses a significant global health threat, with high incidence and mortality rates. In 2022, the Council of the European Union (EU) updated its screening recommendations, prioritizing PCa screening. This signals a crucial step towards establishing new early detection programmes in EU member states. This study investigates the role of policy makers and governance in cancer screening to inform the development of PCa screening. We had a mixed-method study design. First, a rapid review was conducted on policy making and governance in EU-funded cancer screening initiatives. Second, a focus group discussion reviewed study concepts and methods. Third, a systematic literature review was performed and, fourth, a series of in-depth interviews with actors involved in PCa screening pilots was conducted. Data were analysed thematically and the findings are used to propose 10 recommendations for policy makers. The results of the rapid review and focus group discussion framed the study in the context of existing cancer screening programmes across the EU, and highlighted what already exists in terms of governance tools and methodology. The literature review and in-depth interviews presented key learnings from the literature and real-life settings. These findings are reported using a pre-existing conceptional framework for effective health system governance. The study underscores the critical importance of governance in effective cancer screening programmes. Ten recommendations are proposed, including: defining cancer screening governance, allocating budgets and defining common approaches and key performance indicators for evaluation, establishing methods to enhance citizen participation, and reinforcing network governance.

Citovat

COLLEN, Sarah; Arunah CHANDRAN; Paolo GUGLIELMETTI; Ondřej MÁJEK; Monique J ROOBOL; Hendrik VAN POPPEL a Sergio TORRES-RUEDA. Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking. European journal of public health. OXFORD: OXFORD UNIV PRESS, 2025, roč. 35, č. 3, s. 440-446. ISSN 1101-1262. Dostupné z: https://doi.org/10.1093/eurpub/ckaf066.

@article{2507574,
   author = {Collen, Sarah and Chandran, Arunah and Guglielmetti, Paolo and Májek, Ondřej and Roobol, Monique J and Van Poppel, Hendrik and TorresandRueda, Sergio},
   article_location = {OXFORD},
   article_number = {3},
   doi = {https://doi.org/10.1093/eurpub/ckaf066},
   keywords = {prostate cancer screening; European Union; health policy; screening governance; policymaking},
   language = {eng},
   issn = {1101-1262},
   journal = {European journal of public health},
   title = {Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking},
   url = {https://academic.oup.com/eurpub/article/35/3/440/8157805?login=true},
   volume = {35},
   year = {2025}
}

TY  - JOUR
ID  - 2507574
AU  - Collen, Sarah - Chandran, Arunah - Guglielmetti, Paolo - Májek, Ondřej - Roobol, Monique J - Van Poppel, Hendrik - Torres-Rueda, Sergio
PY  - 2025
TI  - Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking
JF  - European journal of public health
VL  - 35
IS  - 3
SP  - 440-446
EP  - 440-446
PB  - OXFORD UNIV PRESS
SN  - 11011262
KW  - prostate cancer screening
KW  - European Union
KW  - health policy
KW  - screening governance
KW  - policymaking
UR  - https://academic.oup.com/eurpub/article/35/3/440/8157805?login=true
N2  - Prostate cancer (PCa) poses a significant global health threat, with high incidence and mortality rates. In 2022, the Council of the European Union (EU) updated its screening recommendations, prioritizing PCa screening. This signals a crucial step towards establishing new early detection programmes in EU member states. This study investigates the role of policy makers and governance in cancer screening to inform the development of PCa screening. We had a mixed-method study design. First, a rapid review was conducted on policy making and governance in EU-funded cancer screening initiatives. Second, a focus group discussion reviewed study concepts and methods. Third, a systematic literature review was performed and, fourth, a series of in-depth interviews with actors involved in PCa screening pilots was conducted. Data were analysed thematically and the findings are used to propose 10 recommendations for policy makers. The results of the rapid review and focus group discussion framed the study in the context of existing cancer screening programmes across the EU, and highlighted what already exists in terms of governance tools and methodology. The literature review and in-depth interviews presented key learnings from the literature and real-life settings. These findings are reported using a pre-existing conceptional framework for effective health system governance. The study underscores the critical importance of governance in effective cancer screening programmes. Ten recommendations are proposed, including: defining cancer screening governance, allocating budgets and defining common approaches and key performance indicators for evaluation, establishing methods to enhance citizen participation, and reinforcing network governance.
ER  -

COLLEN, Sarah; Arunah CHANDRAN; Paolo GUGLIELMETTI; Ondřej MÁJEK; Monique J ROOBOL; Hendrik VAN POPPEL a Sergio TORRES-RUEDA. Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking. \textit{European journal of public health}. OXFORD: OXFORD UNIV PRESS, 2025, roč.~35, č.~3, s.~440-446. ISSN~1101-1262. Dostupné z: https://doi.org/10.1093/eurpub/ckaf066.

Přehled o publikaci